ARTICLE | Company News
Neuralstem neurology news
June 6, 2016 7:00 AM UTC
Neuralstem will reduce headcount across all divisions to focus on developing NSI-189 and pursuing partnerships for NSI-566. NSI-189, a small molecule benzylpiperizine aminiopyridine that stimulates ...